In patients with SS, an imbalance in the ratio of type 1 to type 2 helper T cells (56) leads to excessive interferon-γ (57), IL-17 (58), IL-21 (59), and IL-22 (60) production, which creates an inflammatory microenvironment that can cause tissue damage. Here, IL21 is linked to synovial sarcoma.